Antoinette F. Konski is a partner and intellectual property lawyer with Foley & Lardner LLP. Ms. Konski works with life science clients, creating and optimizing value in intellectual property portfolios encompassing technologies that include personalized medicine, regenerative and stem cell biology, antibodies, immunology, gene therapy, nanotechnology, diagnostics, small molecules and drug delivery. She represents public and private companies and universities. Ms. Konski currently serves as the firm’s Silicon Valley IP office chairperson, vice chair of the Chemical, Biotechnology & Pharmaceutical Practice and co-chair of the Life Sciences Industry Team. She is the editor of the Foley Personalized Medicine blog, PersonalizedMedicineBulletin.com.
Ms. Konski's practice includes: identifying diverse commercial applications for early stage technologies; developing, prosecuting and managing global intellectual property portfolios; advising clients on preparing for due diligence investigations and conducting due diligence of target intellectual property; providing inventorship, patent invalidity, freedom to operate and non-infringement opinions; advising clients on domestic and foreign IP acquisitions; and assisting clients resolve intellectual property disputes in non-litigious forums.
In 2013, Ms. Konski was named one of Silicon Valley’s Women of Influence by the Silicon Valley Business Journal. In 2011, she was selected as a Top 25 IP Portfolio Manager in California and one of 25 Leading Biotech Lawyers in California, each by the Daily Journal. She was recognized by The Legal 500 for her work in the area of health care – life sciences in 2013, 2014, 2015, and 2016 and was also recognized in The Legal 500 US 2009 Edition and in The Legal 500 US: Volume II: Intellectual Property, Media, Technology, and Telecom 2007 Guide as a top attorney for patent prosecution.
Ms. Konski earned her J.D. degree from Fordham University School of Law where she was a member of the Urban Law Journal. She earned her Bachelor of Science degree from the University of Delaware where she was elected to Omicron Nu Honor Society. She is a member of the State Bar of California, the State Bar of New York, the Biotechnology Section of the American Bar Association and the American Intellectual Property Lawyers Association. She is registered to practice before the U.S. Patent and Trademark Office.
Before entering the legal profession, Ms. Konski was employed by Penn State Medical College in a molecular virology laboratory and later by Memorial Sloan-Kettering Cancer Center in a tumor immunology laboratory.